Newer research suggests that deregulation of the mammalian target of rapamycin (mTOR) cell proliferation/survival pathway may play an important role in desmoid tumor biology especially when the APC/β-catenin pathway is disrupted. This evidence concerns the gene MTOR and neoplasm.